Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Care Facilities

Apollo Medical Holdings Inc is a provider of integrated medical management services that focuses on inpatient care plus multi-disciplinary care management services. The Company also services healthcare payer and provider networks.
Website: apollomed.net



Growth: Pretty weak revenue growth rate 7.1%, there is slowdown compared to average historical growth rates 45.6%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +4.7%. In the last quarter the company beat the estimated EPS, 0.0%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -6.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 35.2% higher than minimum and 2.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.5x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: AMEH
Share price, USD:  (0.0%)40.82
year average price 40.82  


year start price 40.82 2025-11-08

max close price 40.82 2025-11-08

min close price 40.82 2025-11-08

current price 40.82 2026-11-08
Common stocks: 49 230 686

Dividend Yield:  0.0%
FCF Yield LTM: -6.5%
EV / LTM EBITDA: 12.9x
EV / EBITDA annualized: 10.8x
Last revenue growth (y/y):  +7.1%
Last growth of EBITDA (y/y):  +57.1%
Historical revenue growth:  +45.6%
Historical growth of EBITDA:  +41.0%
EV / Sales: 0.6x
Margin (EBITDA LTM / Revenue): 4.7%
Fundamental value created in LTM:
Market Cap ($m): 2 010
Net Debt ($m): 356
EV (Enterprise Value): 2 366
Price to Book: 2.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-02-26InvestorPlace

The 3 Most Popular Stocks Owned by Congress in Q1

2024-02-23Zacks Investment Research

Apollo Medical Holdings, Inc. (AMEH) Soars 7.6%: Is Further Upside Left in the Stock?

2024-02-19Zacks Investment Research

ELV or AMEH: Which Is the Better Value Stock Right Now?

2023-12-21PRNewsWire

Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference

2023-11-14Zacks Investment Research

ELV or AMEH: Which Is the Better Value Stock Right Now?

2023-08-08Seeking Alpha

Apollo Medical Holdings Inc. (AMEH) Q2 2023 Earnings Call Transcript

2023-08-07Zacks Investment Research

Apollo Medical Holdings, Inc. (AMEH) Meets Q2 Earnings Estimates

2023-06-20Zacks Investment Research

Is the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?

2023-06-08Zacks Investment Research

3 Medical Services Stocks to Buy Amid Improving Industry Trends

2023-06-07Zacks Investment Research

Wall Street Analysts Believe Apollo Medical Holdings, Inc. (AMEH) Could Rally 59.78%: Here's is How to Trade
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-07 2023-11-09 2023-08-09 2023-05-10 2022-11-07
acceptedDate 2025-11-10 16:28:23 2025-08-07 17:15:59 2025-03-14 08:00:33 2023-12-31 00:00:00 2023-11-09 15:19:03 2023-08-09 17:20:10 2023-05-10 13:49:06 2023-03-01 17:01:07 2022-11-07 17:23:38 2022-02-28 17:20:54 2021-03-12 20:11:00
calendarYear 2025 2025 2023 2023 2023 2022
period Q3 Q2 FY FY Q3 Q2 Q1 FY Q3 FY FY
revenue 1 611M 0 2 035M 1 387M 348M 348M 336M 1 144M 315M 774M 370M
costOfRevenue 0 0 0 1 172M 275M 293M 289M 945M 241M 596M 349M
grossProfit 0 0 0 215M 73M 55M 46M 199M 75M 178M 22M
grossProfitRatio 0 0 0.209 0.159 0.138 0.236
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 113M 0 154M 113M 29M 24M 21M 78M 21M 62M 16M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 113M 0 154M 113M 29M 24M 21M 78M 21M 62M 16M
otherExpenses 0 0 0 6M 2M 1M 3M 4M 3M -4M 0
operatingExpenses 113M 0 154M 130M 34M 28M 24M 95M 24M 80M 16M
costAndExpenses 0 0 0 1 302M 309M 321M 313M 1 040M 265M 676M 364M
interestIncome 4M 2M 15M 14M 3M 3M 3M 2M 223 000 2M 405 000
interestExpense 47M 7M -33M 16M 4M 4M 3M 8M 2M 5M 3M
depreciationAndAmortization 22M 0 28M 18M 4M 4M 11M 29M 5M 11M 26M
ebitda 75M 0 69M 128M 46M 39M 33M 133M 55M 94M 40M
ebitdaratio 0.047 0 0.133 0.111 0.099 0.175
operatingIncome 40M 0 89M 85M 39M 27M 22M 104M 50M 98M 6M
operatingIncomeRatio 0.025 0 0.112 0.078 0.067 0.159
totalOtherIncomeExpensesNet 0 0 -9M 7M -1M 4M -3M -18M -9M 2M -21M
incomeBeforeTax 6M 17M 81M 90M 38M 31M 19M 86M 41M 101M -15M
incomeBeforeTaxRatio 0.004 0 0.109 0.09 0.058 0.131
incomeTaxExpense 5M 7M 31M 32M 10M 14M 5M 41M 14M 32M 9M
netIncome 1M 9M 43M 61M 22M 13M 15M 45M 26M 69M -24M
netIncomeRatio 0.001 0 0.063 0.038 0.044 0.082
eps -0.34 0.2 0.91 1.3 0.47 0.28 0.31 1 0.58 1.57 -0.65
epsdiluted -0.34 0.2 0.47 0.28 0.31 0.56
weightedAverageShsOut 48M 48M 48M 47M 47M 46M 47M 45M 45M 44M 37M
weightedAverageShsOutDil 48M 48M 48M 47M 47M 47M 47M 46M 46M 44M 37M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link
filingDate 2025-03-14 2023-12-31 2023-03-01 2022-02-28 2021-03-15
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 0 -2M -6M -4M -2M
ebit 0 0 95M 83M 14M
nonOperatingIncomeExcludingInterest 0 0 10M 15M -7M
netIncomeFromContinuingOperations 0 0 45M 69M -24M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 43M 61M 45M 69M -24M
epsDiluted 0.9 1.29 0.99 1.52 -0.63

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-07 2023-11-09 2023-08-09 2023-05-10 2022-11-07
acceptedDate 2025-11-10 16:28:23 2025-08-07 17:15:59 2025-03-14 08:00:33 2023-12-31 00:00:00 2023-11-09 15:19:03 2023-08-09 17:20:10 2023-05-10 13:49:06 2023-03-01 17:01:07 2022-11-07 17:23:38 2022-02-28 17:20:54 2021-03-12 20:11:00
calendarYear 2025 2025 2023 2023 2023 2022
period Q3 Q2 FY FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 462M 0 159M 294M 274M 294M 275M 288M 184M 233M 193M
shortTermInvestments 1M 0 2M 2M 3M 4M 4M 6M 33M 53M 68M
cashAndShortTermInvestments 463M 0 161M 296M 277M 298M 279M 294M 217M 287M 261M
netReceivables 456M 16M 115M 148M 185M 152M 157M 120M 215M 99M 61M
inventory 0 0 0 0 0 345 000 0 0 0 0 0
otherCurrentAssets -35M 0 42M 17M 14M 15M 22M 15M 12M 19M 0
totalCurrentAssets 884M 16M 319M 462M 476M 465M 458M 428M 444M 404M 339M
propertyPlantEquipmentNet 90M 32M 27M 45M 150M 142M 132M 129M 120M 69M 48M
goodwill 863M 242M 243M 279M 276M 274M 276M 269M 257M 246M 239M
intangibleAssets 285M 79M 88M 72M 74M 74M 78M 77M 73M 83M 87M
goodwillAndIntangibleAssets 1 148M 321M 331M 350M 350M 348M 354M 346M 331M 329M 326M
longTermInvestments 18M 15M 15M 32M 47M 49M 44M 41M 40M 43M 80M
taxAssets 0 0 0 0 41M 16M 0 16M 0 17M 5M
otherNonCurrentAssets 97M 172M 244M 2M 50M 23M 5M 22M 9M 22M 24M
totalNonCurrentAssets 1 354M 540M 618M 472M 597M 562M 535M 538M 500M 463M 479M
otherAssets 0 323M 0 0 0 0 0 0 0 0 0
totalAssets 2 237M 879M 937M 933M 1 073M 1 027M 993M 966M 943M 867M 817M
accountPayables 4M 5M 8M 9M 15M 19M 58M 10M 54M 6M 10M
shortTermDebt 55M 4M 4M 25M 7M 6M 4M 5M 7M 4M 14M
taxPayables 5M 19M 11M 0 30M 20M 8M 4M 0 0 4M
deferredRevenue 0 0 0 744 000 822 000 647 000 2M 531 000 544 000 17M 13M
otherCurrentLiabilities 565M 164M 210M 117M 149M 140M 100M 125M 95M 78M 69M
totalCurrentLiabilities 630M 192M 223M 219M 203M 186M 165M 149M 156M 115M 115M
longTermDebt 30M 25M 31M 296M 228M 224M 224M 225M 216M 197M 246M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 4M 10M 5M 4M 12M 12M 4M 14M 5M 30M 11M
otherNonCurrentLiabilities 1 018M 4M 439M 4M 14M 21M 22M 20M 173M 15M 0
totalNonCurrentLiabilities 1 053M 38M 475M 304M 255M 258M 250M 259M 234M 242M 257M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 0 0 23M 0 21M 0 0
totalLiabilities 1 682M 230M 256M 523M 458M 444M 415M 408M 390M 357M 372M
preferredStock 0 0 0 0 0 0 0 0 0 0 0
commonStock 49 000 0 48 000 47 000 47 000 47 000 47 000 47 000 45 000 45 000 42 000
retainedEarnings 302M 0 286M 243M 231M 209M 207M 182M 195M 137M 70M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0 0 0 0 0
othertotalStockholdersEquity 473M 648M 363M 357M 353M 315M
totalStockholdersEquity 776M 648M 713M 614M 594M 566M 560M 543M 510M 448M 331M
totalEquity -176M 648M 0 411M 616M 584M 560M 559M 510M 511M 445M
totalLiabilitiesAndStockholdersEquity 1 507M 879M 1 073M 1 027M 993M 943M
minorityInterest 0 0 -203M -203M 22M 18M 18M 16M 0 62M 114M
totalLiabilitiesAndTotalEquity 1 507M 879M 1 355M 933M 1 073M 1 027M 993M 966M 943M 867M 817M
totalInvestments 20M 15M 18M 35M 50M 53M 31M 47M 73M 96M 148M
totalDebt 85M 29M 35M 321M 236M 230M 229M 229M 223M 201M 261M
netDebt -377M 29M -124M 0 -38M -64M -46M -59M 39M -32M 67M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link
filingDate 2025-03-14 2023-12-31 2023-03-01 2022-02-28 2021-03-15
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 115M 0 0 0 0
otherReceivables 0 148M 120M 99M 61M
prepaids 0 0 0 0 0
totalPayables 8M 9M 10M 6M 10M
otherPayables 0 0 0 0 0
accruedExpenses 0 0 0 0 0
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 426M 0 360M 311M 261M

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH AMEH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-10 2025-08-07 2023-11-09 2023-08-09 2023-05-10 2022-11-07
acceptedDate 2025-11-10 16:28:23 2025-08-07 17:15:59 2025-03-14 08:00:33 2023-12-31 00:00:00 2023-11-09 15:19:03 2023-08-09 17:20:10 2023-05-10 13:49:06 2023-03-01 17:01:07 2022-11-07 17:23:38 2022-02-28 17:20:54 2021-03-12 20:11:00
calendarYear 2025 2025 2023 2023 2023 2022
period Q3 Q2 FY FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 1M 10M -8M 58M 28M 17M 14M 46M 27M 46M 122M
depreciationAndAmortization 16M 7M 28M 18M 4M 4M 4M 18M 5M 18M 18M
deferredIncomeTax -3M -2M -4M -12M -190 000 -4M 790 000 -14M -5M 8M 396 000
stockBasedCompensation 8M 12M 35M 22M 6M 4M 3M 16M 4M 7M 3M
changeInWorkingCapital -52M 0 0 -23M -25M 7M -19M 2M -73M -31M 4M
accountsReceivables 10M 0 0 -21M -33M 1M -36M -34M -12M -22M 3M
inventory 0 0 0 0 -1M -4M 0 31M 0 1M -8M
accountsPayables 3M -8000 -31M -498 000 -601 000 1M -4M -3M -13M 4M 16M
otherWorkingCapital -65M 0 0 -14M 9M 5M 20M 38M -48M -13M -15M
otherNonCashItems 40M 64M 2M 9M 3M -3M 4M 15M 6M 23M -102M
netCashProvidedByOperatingActivities 10M 91M 52M 68M 15M 26M 8M 82M -36M 70M 46M
investmentsInPropertyPlantAndEquipment -3M -4M -8M -29M -4M -3M -15M -23M -3M -19M -1M
acquisitionsNet -549M 0 -146M -8M -6M 350 000 -325 000 -18M -5M -4M 31M
purchasesOfInvestments 0 0 -12M -6M -103 000 -3M -1 000 000 -2M 0 -28M -2M
salesMaturitiesOfInvestments 15M 0 124 000 491 000 0 0 0 32M -42 000 68M 51M
otherInvestingActivites 2M 1M -25M 2000 2M 21 000
netCashUsedForInvestingActivites -534M -3M -35M -5M -14M -8M
debtRepayment 0 0 0 0 -307 000 -4M
commonStockIssued 301 000 0 0 0 0 0
commonStockRepurchased 0 0 0 -10M -150 000 0 -10M -9M -168 000 -6M -537 000
dividendsPaid -96 000 -6M -1M -722 000 -120 000 -120 000
otherFinancingActivites 649M -47M 914 000 -241 000 3M -2M
netCashUsedProvidedByFinancingActivities 648M -53M -510 000 -963 000 -7M -6M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash 0 0 0 6M -20M 20M -13M 55M -50M 39M 90M
cashAtEndOfPeriod 464M 0 0 294M 274M 294M 275M 288M 184M 233M 194M
cashAtBeginningOfPeriod 340M 0 0 288M 294M 275M 288M 233M 234M 194M 104M
operatingCashFlow 10M 91M 52M 68M 15M 26M 8M 82M -36M 70M 46M
capitalExpenditure -3M -4M -8M -29M -4M -3M -15M -23M -3M -19M -1M
freeCashFlow 7M 86M 44M 40M 11M 23M -7M 59M -39M 51M 45M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link
filingDate 2025-03-14 2023-12-31 2023-03-01 2022-02-28 2021-03-15
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -26M -24M 4M 56 000 16M
netCashProvidedByInvestingActivities -192M -66M -7M 17M 95M
netDebtIssuance 0 0 0 0 0
longTermNetDebtIssuance 0 0 0 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 0 0 0 0
netCommonStockIssuance 0 0 0 0 0
commonStockIssuance 0 0 12M 40M 11M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 -62M -14M -31M -51M
commonDividendsPaid 0 -62M -14M -31M -51M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 0 -5M -6M -17M -377 000
netCashProvidedByFinancingActivities 0 3M -20M -48M -52M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-08 ET (fiscal 2025 q2)
2025 q1
2025-05-08 ET (fiscal 2025 q1)
2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-11-09 ET (fiscal 2024 q3)
2024 q2
2024-08-07 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-27 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-24 ET (fiscal 2022 q4)
2022 q3
2022-11-04 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-22 13:00 ET
Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.
2024-01-31 13:00 ET
Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call
2024-01-29 13:00 ET
ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership
2024-01-24 13:05 ET
Apollo Medical Holdings, Inc. Announces Leadership Transitions
2024-01-24 13:00 ET
Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health
2024-01-24 12:00 ET
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
2023-12-21 21:10 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference
2023-12-18 21:10 ET
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
2023-11-13 21:05 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference
2023-11-07 21:15 ET
Apollo Medical Holdings, Inc. Reports Third Quarter 2023 Results
2023-11-07 21:10 ET
Apollo Medical Holdings, Inc. Announces Definitive Agreement to Acquire Assets of Community Family Care Medical Group IPA, Inc. and Health Plan
2023-11-07 14:15 ET
ApolloMed and Wider Circle Enter Strategic Partnership to Elevate the Delivery of Patient-Centered Care for High-Need Community Members
2023-10-19 20:05 ET
Apollo Medical Holdings, Inc. Schedules 2023 Third Quarter Financial Results Release and Conference Call
2023-09-27 12:05 ET
Apollo Medical Holdings, Inc. Releases Inaugural ESG At-a-Glance Report, Highlighting its Commitment to Advancing Health Equity in Local Communities
2023-09-05 12:05 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conferences
2023-08-07 21:17 ET
/C O R R E C T I O N -- Apollo Medical Holdings, Inc./
2023-08-07 21:17 ET
Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results
2023-07-31 12:05 ET
Apollo Medical Holdings, Inc. Announces Partnership with IntraCare to Advance Value-Based Care in Texas and Oklahoma
2023-07-28 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2023 Second Quarter Financial Results Release and Conference Call
2023-07-12 12:05 ET
Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston
2023-06-22 12:05 ET
Apollo Medical Holdings, Inc. Receives NCQA's HEDIS Health Plan Measure Certification for Measurement Year 2023
2023-05-08 20:05 ET
Apollo Medical Holdings, Inc. Reports First Quarter 2023 Results
2023-04-26 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2023 First Quarter Financial Results Release and Conference Call
2023-03-06 13:05 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conferences
2023-02-23 21:35 ET
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results
2023-02-09 13:05 ET
Apollo Medical Holdings, Inc. Schedules 2022 Fourth Quarter and Year-end Financial Results Release and Conference Call
2023-01-22 23:40 ET
Apollo Medical Holdings, Inc. Releases Statement on the Mass Shooting in Monterey Park, Calif.
2023-01-05 13:05 ET
Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year
2022-12-20 13:05 ET
Apollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference
2022-12-15 21:50 ET
Apollo Medical Holdings, Inc. Announces Share Repurchase Program
2022-11-17 13:05 ET
Apollo Medical Holdings, Inc. Receives NCQA's HEDIS Health Plan Measure Certification for Measurement Year 2022
2022-11-03 22:00 ET
Apollo Medical Holdings, Inc. Reports Third Quarter 2022 Results, Raises Revenue, Net Income and EBITDA Guidance for Full-Year 2022
2022-10-21 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2022 Third Quarter Financial Results Release and Conference Call
2022-10-05 20:05 ET
Apollo Medical Holdings, Inc. Expands into Nevada and Texas with Acquisition of Valley Oaks Medical Group
2022-09-26 12:05 ET
Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire All American Medical Group and For Your Benefit
2022-09-21 12:05 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Virtual Investor Conferences
2022-08-04 20:15 ET
Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results
2022-07-21 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2022 Second Quarter Financial Results Release and Conference Call
2022-05-11 12:05 ET
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
2022-05-05 20:05 ET
Apollo Medical Holdings, Inc. Reports First Quarter 2022 Results
2022-05-05 20:05 ET
Apollo Medical Holdings, Inc. Announces Appointment of Chief Strategy Officer and CFO Transition
2022-04-28 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2022 First Quarter Financial Results Release and Conference Call
2022-03-09 13:05 ET
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
2022-02-24 21:47 ET
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results
2022-02-10 13:05 ET
Apollo Medical Holdings, Inc. Schedules 2021 Fourth Quarter and Year-end Financial Results Release and Conference Call
2022-01-27 13:05 ET
Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health, Welcomes New Chief Analytics Officer and President of Provider Solutions
2022-01-05 17:00 ET
Society 1 and ApolloMed Stand in Solidarity for the AAPI Community at Holiday Broadway Concert
2022-01-04 13:05 ET
Apollo Medical Holdings, Inc. to Present at 40th Annual J.P. Morgan Healthcare Conference
2021-12-21 21:05 ET
Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire Jade Health Care Medical Group
2021-12-20 13:05 ET
Apollo Medical Holdings, Inc. Appoints Weili Dai and J. Lorraine Estradas to its Board of Directors
2021-11-04 20:06 ET
Apollo Medical Holdings, Inc. Reports Third Quarter 2021 Results, Raises Full-Year 2021 Guidance
2021-11-04 20:05 ET
Apollo Medical Holdings, Inc. Appoints Brandon Sim as Co-Chief Executive Officer
2021-11-03 12:05 ET
Apollo Medical Holdings, Inc. Announces Signing of Agreement to Purchase the Remaining 60% of Equity Interests of Diagnostic Medical Group of Southern California Within Three Years
2021-11-02 12:05 ET
Apollo Medical Holdings, Inc. to Present at Credit Suisse 30th Annual Healthcare Conference
2021-10-21 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2021 Third Quarter Financial Results Release and Conference Call
2021-09-23 20:05 ET
Clinigence Holdings Announces The Completion Of A $3 Million Strategic Equity Investment From Apollomed
2021-09-16 12:05 ET
Apollo Medical Holdings, Inc. to Present at the 2021 Cantor Virtual Global Healthcare Conference
2021-09-01 12:05 ET
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conferences
2021-08-31 14:00 ET
Apollo Medical Holdings, Inc. Announces Closing of CAIPA MSO Strategic Investment
2021-08-05 20:05 ET
Apollo Medical Holdings, Inc. Reports Second Quarter 2021 Results, Raises Full-Year 2021 Guidance
2021-07-21 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2021 Second Quarter Financial Results Release and Conference Call
2021-07-19 12:05 ET
Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire a Controlling Stake in Access Primary Care Medical Group
2021-06-25 12:05 ET
Apollo Medical Holdings, Inc. Affiliate Allied Pacific of California IPA to Partner with Shriners Children's Southern California in Opening a New Specialty Pediatric Satellite Clinic
2021-06-17 12:05 ET
Apollo Medical Holdings, Inc. Announces Successful Completion of Debt Refinancing, Reducing Annual Interest Rate Spread by 50 Basis Points
2021-06-15 12:05 ET
Apollo Medical Holdings, Inc. Promotes Chief of Staff Jeremy R. Jackson, M.D., to Chief Quality Officer
2021-06-14 12:05 ET
Apollo Medical Holdings, Inc. to Join S&P SmallCap 600
2021-06-02 12:05 ET
Apollo Medical Holdings, Inc. Announces Purchase of Controlling Interests in Sun Clinical Laboratories
2021-05-11 12:05 ET
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
2021-05-05 20:05 ET
Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results
2021-04-21 12:05 ET
Apollo Medical Holdings, Inc. Schedules 2021 First Quarter Financial Results Release and Conference Call
2021-03-10 21:05 ET
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2020 Results, Highlighted by Record Revenue and Net Income Growth for 2020 and Annual Guidance Beat
2021-03-02 13:05 ET
Apollo Medical Holdings, Inc. Appoints Jeremy R. Jackson, M.D., as Chief of Staff
2021-02-25 13:05 ET
Apollo Medical Holdings, Inc. to Present at Barclays Global Healthcare Conference
2021-02-23 13:05 ET
Apollo Medical Holdings, Inc. Schedules 2020 Fourth Quarter and Year-end Financial Results Release and Conference Call
2021-02-16 13:05 ET
Apollo Medical Holdings, Inc. Announces APA ACO Achieved $19.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2019 Performance Year
2021-02-09 13:05 ET
Apollo Medical Holdings, Inc. Promotes Chief Technology Officer Brandon Sim to Chief Operating Officer
2021-01-26 13:37 ET
Apollo Medical Holdings, Inc. and CAIPA MSO, LLC Announce Strategic Alliance in New York
2021-01-26 13:05 ET
Apollo Medical Holdings, Inc. and CAIPA MSO, LLC Announce Strategic Alliance in New York
2020-11-05 21:10 ET
Apollo Medical Holdings, Inc. to Present at Credit Suisse 29th Annual Healthcare Conference
2020-11-04 21:05 ET
Apollo Medical Holdings, Inc. Reports Third Quarter 2020 Results, Raises Full-Year 2020 Guidance
2020-10-22 12:45 ET
Apollo Medical Holdings, Inc. to Release Third Quarter 2020 Financial Results on November 4, 2020
2020-08-07 12:30 ET
Apollo Medical Holdings, Inc. Reports Second Quarter Ended June 30, 2020 Results
2020-05-27 20:05 ET
Apollo Medical Holdings, Inc. Reports First Quarter Ended March 31, 2020 Results
2020-03-12 10:00 ET
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Results
2019-11-08 00:22 ET
Apollo Medical Holdings, Inc. Reports: 3Q19 Total Revenues of $156.1 Million, Up 20.0% Over 2Q19; 3Q19 Adjusted EBITDA of $22.8 Million, Up 55.6% Over 3Q18; Capitated Membership of Over One Million Managed Lives; and Elite Status Awarded by APG
2019-10-02 20:02 ET
Apollo Medical Holdings Adds Approximately 145,000 Members By Entering Into New Management Services Agreement
2019-09-30 13:06 ET
Apollo Medical Holdings Announces The Appointment Of Matthew Mazdyasni To Its Board Of Directors And Appointment Of New Interim Chief Technology Officer
2019-09-11 21:41 ET
Apollo Medical Holdings Announces The Closing Of Its Inaugural $290 Million Syndicated Credit Facility And Series Of Transactions With Independent Practice Association And Professional Medical Corporation
2019-09-05 22:00 ET
Apollo Medical Holdings Announces Acquisition Of Accountable Health Care IPA
2019-08-09 20:01 ET
Apollo Medical Holdings Reports Revenue Of $130.0 Million For The Second Quarter Of 2019
2019-06-04 20:10 ET
Apollo Medical Holdings Announces Acquisition Of Alpha Care Medical Group
2019-05-13 13:00 ET
Apollo Medical Holdings Announces Signing Of Agreements With Independent Practice Association And Professional Medical Corporation And Reports Results Of The First Quarter Of 2019

SEC forms

Show financial reports only

SEC form 10
2026-11-06 00:00 ET
Apollo Medical published news for 2026 q3
SEC form 8
2026-11-05 00:00 ET
Apollo Medical published news for 2026 q3
SEC form 8
2026-11-05 00:00 ET
Apollo Medical reported for 2026 q3
SEC form 8
2026-11-05 00:00 ET
Apollo Medical published news for 2026 q3
SEC form 10
2026-08-10 21:03 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-08-06 20:11 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-08-06 20:11 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-08-06 20:11 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-07-13 12:05 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-07-13 12:05 ET
Apollo Medical published news for 2026 q2
SEC form 8
2026-05-12 10:03 ET
Apollo Medical published news for 2026 q1
SEC form 8
2026-05-12 10:03 ET
Apollo Medical published news for 2026 q1
SEC form 10
2026-05-08 10:01 ET
Apollo Medical published news for 2026 q1
SEC form 8
2026-05-07 20:12 ET
Apollo Medical published news for 2026 q1
SEC form 8
2026-05-07 20:12 ET
Apollo Medical published news for 2026 q1
SEC form 8
2026-05-07 20:12 ET
Apollo Medical published news for 2026 q1
SEC form 8
2026-03-30 21:33 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-30 21:33 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-30 21:33 ET
Apollo Medical published news for 2025 q4
SEC form 10
2026-03-12 12:11 ET
Apollo Medical reported for 2025 q4
SEC form 8
2026-03-04 12:30 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-04 12:30 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-02 12:11 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-02 12:11 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-03-02 12:11 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-01-12 21:06 ET
Apollo Medical published news for 2025 q4
SEC form 8
2026-01-12 21:06 ET
Apollo Medical published news for 2025 q4
SEC form 10
2025-11-10 21:28 ET
Apollo Medical published news for 2025 q3
SEC form 8
2025-11-06 21:19 ET
Apollo Medical published news for 2025 q3
SEC form 8
2025-11-06 21:19 ET
Apollo Medical reported for 2025 q3
SEC form 8
2025-11-06 21:19 ET
Apollo Medical published news for 2025 q3
SEC form 10
2025-08-07 21:15 ET
Apollo Medical reported for 2025 q2
SEC form 8
2025-08-07 20:14 ET
Apollo Medical published news for 2025 q2
SEC form 8
2025-08-07 20:14 ET
Apollo Medical published news for 2025 q2
SEC form 8
2025-08-07 20:14 ET
Apollo Medical published news for 2025 q2
SEC form 8
2025-06-04 10:03 ET
Apollo Medical published news for 2025 q1
SEC form 8
2025-06-04 10:03 ET
Apollo Medical published news for 2025 q1
SEC form 8
2025-05-13 20:15 ET
Apollo Medical published news for 2025 q1
SEC form 8
2025-05-13 20:15 ET
Apollo Medical published news for 2025 q1
SEC form 10
2025-05-09 21:02 ET
Apollo Medical published news for 2025 q1
SEC form 10
2025-05-09 00:00 ET
Apollo Medical published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Apollo Medical published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Apollo Medical reported for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Apollo Medical published news for 2025 q1
SEC form 10
2025-03-14 12:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-14 11:47 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-14 11:47 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-14 11:47 ET
Apollo Medical published news for 2024 q4
SEC form 10
2025-03-14 00:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-10 12:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-10 12:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-03 13:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-03-03 13:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-02-27 00:00 ET
Apollo Medical published news for 2024 q4
SEC form 8
2025-02-27 00:00 ET
Apollo Medical reported for 2024 q4
SEC form 8
2025-02-27 00:00 ET
Apollo Medical published news for 2024 q4
SEC form 10
2024-11-12 14:22 ET
Apollo Medical reported for 2024 q3
SEC form 10
2024-11-12 00:00 ET
Apollo Medical reported for 2024 q3
SEC form 8
2024-11-07 17:14 ET
Apollo Medical published news for 2024 q3
SEC form 8
2024-11-07 17:14 ET
Apollo Medical published news for 2024 q3
SEC form 8
2024-11-07 17:14 ET
Apollo Medical published news for 2024 q3
SEC form 10
2024-08-09 00:00 ET
Apollo Medical published news for 2024 q2
SEC form 8
2024-08-07 00:00 ET
Apollo Medical published news for 2024 q2
SEC form 8
2024-08-07 00:00 ET
Apollo Medical reported for 2024 q2
SEC form 8
2024-08-07 00:00 ET
Apollo Medical published news for 2024 q2
SEC form 10
2024-05-09 00:00 ET
Apollo Medical published news for 2024 q1
SEC form 8
2024-05-07 00:00 ET
Apollo Medical published news for 2024 q1
SEC form 8
2024-05-07 00:00 ET
Apollo Medical reported for 2024 q1
SEC form 8
2024-05-07 00:00 ET
Apollo Medical published news for 2024 q1
SEC form 10
2024-02-29 00:00 ET
Apollo Medical published news for 2023 q4
SEC form 8
2024-02-27 16:19 ET
Apollo Medical published news for 2023 q4
SEC form 8
2024-02-27 16:19 ET
Apollo Medical reported for 2023 q4
SEC form 8
2024-02-27 16:19 ET
Apollo Medical published news for 2023 q4
SEC form 10
2023-11-09 00:00 ET
Apollo Medical published news for 2023 q3
SEC form 8
2023-11-07 16:30 ET
Apollo Medical reported for 2023 q3
SEC form 10
2023-08-09 00:00 ET
Apollo Medical published news for 2023 q2
SEC form 6
2023-08-07 17:28 ET
Apollo Medical reported for 2023 q2
SEC form 6
2023-08-07 16:50 ET
Apollo Medical published news for 2023 q2
SEC form 8
2023-08-07 00:00 ET
Apollo Medical published news for 2023 q2
SEC form 6
2023-07-31 08:15 ET
Apollo Medical published news for 2023 q2
SEC form 6
2023-07-12 16:09 ET
Apollo Medical published news for 2023 q2
SEC form 6
2023-06-16 16:32 ET
Apollo Medical published news for 2023 q1
SEC form 6
2023-06-07 10:20 ET
Apollo Medical published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Apollo Medical published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
Apollo Medical published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Apollo Medical reported for 2022 q4
SEC form 8
2023-02-23 00:00 ET
Apollo Medical reported for 2022 q4
SEC form 10
2022-11-07 00:00 ET
Apollo Medical reported for 2022 q3
SEC form 8
2022-11-04 00:00 ET
Apollo Medical published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Apollo Medical reported for 2022 q3
SEC form 10
2022-08-09 00:00 ET
Apollo Medical reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Apollo Medical reported for 2022 q2
SEC form 10
2022-05-10 00:00 ET
Apollo Medical reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Apollo Medical reported for 2022 q1
SEC form 10
2022-02-28 00:00 ET
Apollo Medical published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Apollo Medical published news for 2021 q4
SEC form 8
2022-01-12 00:00 ET
Apollo Medical published news for 2021 q4
SEC form 10
2021-11-05 00:00 ET
Apollo Medical published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Apollo Medical published news for 2021 q3
SEC form 10
2021-08-06 00:00 ET
Apollo Medical published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Apollo Medical published news for 2021 q2
SEC form 10
2021-05-07 00:00 ET
Apollo Medical published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Apollo Medical published news for 2021 q1